JosephRubinMD

PubMed

• 89 citations
  Surgical management of left-sided carcinoid heart disease
  Heidi M. Connolly, Hartzell V. Schaff, Charles J. Mullany, Joseph Rubin, Martin D. Abel
  Circulation. 2001-09-18
• 194 citations
  Prognosis of Carcinoid Heart Disease Analysis of 200 Cases Over Two Decades
  Jacob E. Møller, Patricia A. Pellikka, Alain M. Bernheim, Hartzell V. Schaff, Joseph Rubin
  Circulation. 2005-11-22
• 282 citations
  Octreotide Acetate Long-Acting Formulation Versus Open-Label Subcutaneous Octreotide Acetate in Malignant Carcinoid Syndrome
  Joseph Rubin, Jaffer A. Ajani, William Schirmer, Alan P. Venook, Ronald Bukowski
  Journal of Clinical Oncology. 1999-02-01

Journal Articles

• Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers  
  Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kas..., J Oncol Pract, 5/1/2012
• Use of KW-2189, a DNA Minor Groove-Binding Agent, in Patients with Hepatocellular Carcinoma: A North Central Cancer Treatment Group (NCCTG) Phase II Clinical Trial  
  Alberts SR, Suman VJ, Pitot HC, Camoriano JK, Rubin J, Int J Gastrointest Cancer, 1/3/2008
• Phase II study of intratumoral gene transfer of Allovectin-7 (plasmid DNA encoding HLA-B7 complexed with cationic lipid) in HLA-B7 negative patients with metastatic me...  
  Hersh EM, Stopeck AT, Unger EC, Warneke JA, Silver HK, Klasa R, Doroshow JH, Rubin J, Galanis E, Rhinehart JJ, Cancer Gene Ther, 1/1/2003
• Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors  
  Adjei AA, Reid JM, Diasio RB, Sloan JA, Smith DA, Rubin J, Pitot HC, Alberts SR, Goldberg RM, Hanson LJ, Atherton P, Ames MM, Erlichman C, J Clin Oncol, 3/15/2002
• Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumours  
  Kinney MA, Warner ME, Nagorney DM, Rubin J, Schroeder DR, Maxson PM, Warner MA, Br J Anaesth, 9/1/2001
• Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: phase I/II experience  
  Galanis E, Hersh EM, Stopeck AT, Gonzalez R, Burch P, Spier C, Akporiaye ET, Rinehart JJ, Edmonson J, Sobol RE, Forscher C, Sondak VK, Lewis BD, Unger EC, O'Driscoll M..., J Clin Oncol, 10/1/1999
• Carcinoid syndrome  
  Galanis E, Kvols LK, Rubin J, J Clin Oncol, 2/1/1998
• Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer  
  O'Connell MJ, Laurie JA, Kahn M, Fitzgibbons RJ Jr, Erlichman C, Shepherd L, Moertel CG, Kocha WI, Pazdur R, Wieand HS, Rubin J, Vukov AM, Donohue JH, Krook JE, Figuer..., J Clin Oncol, 1/1/1998
• Octreotide acetate long acting release (OALAR): 5-HIAA response in a randomized multi-center double-blind trial in carcinoid syndrome  
  Anthony L, Ajani J, Schirmer W, Venook A, Bukowski R, Pommier R, Saltz L, Dandona P, Rubin J, J Clin Oncol, 1/1/1998
• Diagnosis in oncology  
  Skarin A, Galanis E, Kvols LK, Rubin J, J Clin Oncol, 1/1/1998
• Relation between fat malabsorption and transit abnormalities in human carcinoid iarrhea  
  Saslow SB, Camilleri M, Thomforde GM, Van Dyke CT, Pitot HC, Rubin J, Gastroenterology, 2/1/1996
• Genitourinary radiology  
  Choyke PL, Bush W, Hartman D, King B, Rubin J, Sandler C, Scoutt L, Radiology, 2/1/1994
• Multifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisole  
  Hook CC, Kimmel DW, Kvols LK, Scheithauer BW, Forsyth PA, Rubin J, Moertel CG, Rodriguez M, Ann Neurol, 3/1/1992
• A clinical trial of biochemical modulation of five-fluorouracil with N-phosphonoacetyl-l-aspartate and thymidine in advanced gastric and anaplastic colorectal cancer  
  Windschitl HE, O'Connell MJ, Wieand HS, Krook JE, Rubin J, Moertel CG, Kugler JW, Pfeifle DM, Goldberg RM, Laurie JA, Cancer, 9/1/1990
• Adjuvant chemotherapy with mephalan versus CFP with or without irradiation following mastectomy in patients with prognostically unfavorable breast cancer  
  Ahmann DL, O'Fallon JR, Scanlon PW, Payne WS, Bisel HF, Edmonson JH, Frytak S, Hahn RG, Ingle JN, Rubin J, Creagan ET, Treatment of Early Breast Cancer, 1/1/1990
• Flavone-8-acetic acid, an anticancer drug, inhibits von willebrand factor mediated platelet function  
  Rubin J, Ames MM, Schutt AJ, Fitch TR, Cole TL, Bowie EJW, Kovach JS, Lancet, 1/1/1988
• Prolongation of the disease-free interval in surgically treated rectal carcinoma  
  Moertel CG, Weiland LH, O'Connell MJ, Schutt AJ, Rubin J, McIllrath DC, Childs DSJ, et al, N Engl J Med, 6/6/1985
• Phase II trials of hexamethylmelamine, dianhydrogalactitol, razoxane, and beta-2-deoxythioguanosine as single agents against advanced measurable tumors of the pancreas  
  Moertel CG, O'Connell MJ, Rubin J, Schutt AJ, Reitemeier RJ, et al, Cancer Treat Rep, 6/1/1985
• Phase II trials of maytansine, low-dose chlorozotocin, and high-dose chlorozotocin as single agents against advanced measurable adenocarcinoma of the pancreas  
  Moertel CG, O'Connell MJ, Rubin J, Schutt AJ, Reitemeier RJ, et al, Cancer Treat Rep, 4/1/1985
• A randomized double blind comparison of high dose vitamin c and placebo in the treatment of advanced cancer patients with no prior chemotherapy  
  Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ, Ames MM, N Eng J Med, 1/1/1985
• Adjuvant therapy of colon cancer-results of a prospectively randomized trial  
  Lessner HE, Mayer RJ, Ellenberg SS, Holyoke ED, Moertel CG, O'Connell MJ, Schutt AJ, Rubin J, McIllrath DC, Hahn RG, Weiland LH, et al, N Engl J Med, 3/22/1984
• A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on th...  
  Ahmann DL, O'Fallon JR, Scanlon PW, Payne WS, Bisel HF, Edmonson JH, Frytak S, Hahn RG, Ingle JN, Rubin J, Creagan ET, Am J Clin Oncol, 8/1/1982
• A comparative clinical assessment of combination chemotherapy in the management of advanced gastric carcinoma  
  O'Fallon JR, O'Connell MJ, Moertel CG, Creagan ET, Frytak S, Hahn RG, Reitemeier RJ, Rubin J, Schutt AJ, et al, Cancer, 4/1/1982
• Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer  
  O'Connell MJ, Schutt AJ, Rubin J, Moertel CG, McIllrath DC, Weiland LH, Hahn RG, et al, Cancer, 3/15/1982
• Die Chemotherapie beim Adenokarzinom des Rektums  
  Rubin J, 1/1/1982
• Join now to see all

Books/Book Chapters

• Tumor Ablation: Principles and Practice 
  Chapter: Image-guided palliation of painful skeletal metastases. 
  Page 377 - 388Callstrom MR, Charboneau JW, Goetz MP, Rubin JEditors: VanSonneberg R, McMullen WN Solbiati L.Springer, New York2005
• Endocrine Pathology: Differential Diagnosis and Molecular Advances 
  Chapter: Medical treatment of advanced neuroendocrine tumors. 
  Page 395 - 398Hobday TJ, Rubin JEditors: Lloyd RV.Humana Press, Totowa, NJ2004
• Endocrine Pathology (a textbook) 
  Chapter: Medical treatment of gastrointestinal neuroendocrine tumors. 
  Hobday TJ, Rubin JEditors: Loyd RV.Humana Press, Totowa, NJ2003
• Examining Holistic Medicine 
  Chapter: Failure of high dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer: A controlled trial. 
  Creagan ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J, Frytak SPrometheus Books, Buffalo, NY1985
• Cheotherapy: A Handbook For The Patient and Family 
  Rubin J, May C1980
• Immunotherapy of Cancer: Present Status of Trials in Man 
  Chapter: A controlled evaluation of combined immunotherapy MER-BCG) and chemotherapy for advanced colorectal cancer. 
  Page 573 - 586Moertel CG, O'Connell MJ, Ritts RE Jr, Schutt AJ, Reitemeier RJ, Hahn RG, Frytak S, Rubin JRaven Press, New York1979
• Join now to see all

Abstracts/Posters

• Pilot study of tigatuzumab (cs-1008) in combination with folfiri in patients with metastatic colorectal cancer (crc).
  Kim G, Borad M, Pitot H, Rubin J, Greenberg J, McCroskery P, Beckman R, Grothey A, Ann Oncol, 9/1/2012
• Invited Commentary.
  Rubin J, Ann Thorac Surg, 1/1/2009
• Meta-analyses of randomized trials assessing the interest of postoperative adjuvant chemotherapy in gastric cancer.
  Sakamoto J, Paoletti X, Global Adv/Adj Stomach Tumor Research through International Collaboration (GASTRIC), J Clin Oncol, 5/20/2008
• Elderly patients with metastatic esophageal/gastric cancer: a pooled analysis of age-based outcomes from 8 consecutive North Central Cancer Treatment Group (NCCTG) the...
  Jatoi A, Foster NR, Egner J, Burch P, Stella PJ, Rubin J, Dakhil SR, Sargent DJ, Murphy B, Alberts SR, J Clin Oncol, 1/1/2008
• The role of hepatic resection in patients with carcinoid heart disease.
  Bernheim AM, Connolly HM, Rubin J, Moller JE, Scott C, Nagorney DM, Pellikka PA, J Am Coll Cardiol, 3/1/2007
• A new immunochemiluminometric assay for chromogranin A in serum samples.
  Preissner CM, Folch NV, Rubin J, Grebe SK, Clin Chem, 1/1/2006
• Pemetrexed and Oxaliplatin (OXAL) for Metastatic Colorectal Cancer (MCRC): Results of a Phase I Mayo Cancer Center Research Consortium (MCCRC) Trial.
  Alberts S, Kim G, Mahoney M, Gornet M, Rubin J, Ames M, Goetz M, Weinshilboum R, Nicol S, Goldberg R, Proc Am Soc Clin, 1/1/2006
• A phase I dose escalation study of irinotecan (CPT-11), oxaliplatin (Oxal), and capecitabine (Cap) within three UGT1A1 TA promoter cohorts (6/6, 6/7, and 7/7).
  Goetz MP, Safgren S, Goldberg RM, Grothey AF, Mandrekar SJ, Reid JM, Erlichman C, Adjei AA, Rubin J, Ames MM, J Clin Oncol, 6/1/2005
• RASSF1A expression and gene methylation in ileal carcinoid tumors.
  Rumilla KM, Zhang H, Erickson LA, Hobday TJ, Rubin J, Erlichman C, Ames MM, Lloyd RV, Mod Pathol, 1/1/2005
• RASSF1-A expression and gene methylation in ileal carcinoid tumors.
  Rumilla KM, Zhand H, Erickson LA, Hobday TJ, Rubin J, Erlichman C, Ames MM, Lloyd RV, Lab Invest, 1/1/2005
• Spectrum of malignant somatostatin producing neuroendocrine tumors.
  Joseph Rubin, MD, Endo Society 2003, Philadelphia, PA, 6/1/2003
• Molecular markers in metastatic neuroendocrine tumors.
  Hobday T, Rubin J, Lloyd R, Proc Am Soc Clin Oncol, 1/1/2003
• Molecular markers in metastatic gastrointesintal neuroendocrine tumors.
  Hobday TJ, Rubin J, Goldberg R, Erlichman C, Lloyd R, Proc Am Soc Clin Oncol, 1/1/2003
• Carcinoid heart disease: Factors involved in development and progression.
  Moller JE, Connolly HM, Rubin J, Seward JB, Modesto K, Pellikka PA, Circulation, 11/5/2002
• Percutaneous CT/US-guided radiofrequency ablation of painful metastases involving bone: a multicenter, international study.
  Callstrom MR, Charboneau JW, Goetz MP, Rubin J, Beres R, Regge D, Radiology, 11/1/2002
• Prospective comparison of PET, CT and EUS in the initial staging of esophageal cancer patients: Preliminary results.
  Lowe VJ, Mullan BP, Wiersema M, Vazquez-Sequeiros E, Murray JA, Rubin J, Allen MS, Miller D, Smyrk TC, Jensen EA, Nathan M, Fletcher JG, J Nucl Med, 5/1/2002
• Phase I/II Trial of ONYX-015 in Combination with Chemotherapy in Patients with Advanced Sarcomas.
  Joseph Rubin, MD, ONYX Pharmaceuticals, American Association for Cancer Research, San Francisco, CA, 4/1/2002
• A Phase 1 trial of flavopiridol combined with cisplatin in patients with advanced malignancies.
  Bible KC, Lensing JL, Nelson SA, Daiss MK, Lee YK, Rubin J, Kaufmann SH, Erlichman C, Proc Annu Meet Am Assoc Cancer Res, 3/1/2002
• Phase I/II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas.
  Galanis E, Okuno SH, Lewis BD, Oliveira AM, Nascimento A, Sloan JA, Edmonson JH, Randlev B, Freeman S, Rubin, Proc Am Assoc Cancer Res Annu Meet, 3/1/2002
• A phase II trial of CPT-11 and docetaxel in patients with metastatic esophageal cancer: preliminary toxicity data from the North Central Cancer Treatment Group.
  Tria Tirona M, Jatoi A, Cha SS, Rowland KM, Alberts SR, Morton RF, Nair S, Rubin J, Kardinal CG, Stella PJ, Mailliard JA, Goldberg RM, Proc Am Soc Clin Oncol, 1/1/2002
• Intra-arterial administration of a replication-selective adenovirus ONYX-015 in patients with colorectal carcinoma metastatic to the liver: safety, feasability and bio...
  Reid TR, Galanis E, Sze D, Rubin J, Abbruzzese JL, Kirn D, Freeman S, Program/Proc Am Soc Clin Oncol, 1/1/2002
• 5-HIAA versus chromogranin A as biochemical markers in the malignant carcinoid syndrome: results from a randomized multi-institutional clinical trial.
  Anthony LB, Vance D, Rubin J, Ajani JA, Stridsberg M, Program/Proc Am Soc Clin Oncol, 1/1/2002
• Percutaneous US and CT-guided radiofrequency ablation of painful metastases involving bone.
  Goetz MP, Rubin J, Callstrom MR, Charboneau JW, Wong GY, Sloan JA, Novotny PJ, Lewis BD, Welch TJ, Farrell MA, Maus TP, Lee RA, Reading CC, Saker MB, Nemcek AA, Peters..., Program/Proc Am Soc Clin Oncol, 1/1/2002
• Phase I/II trial of ONYX-015 in combination with chemotherapy in patients with advanced sarcomas. (Abstract 646).
  Galanis E, Okuno S, Lewis BS, Oliveira A, Nascimento AG, Sloan JA, Edmonson JH, Randlev B, Uprichard M, Rubin J, Clin Cancer Res, 11/1/2001
• A phase IB study evaluating the scheduling and pharmacokinetic interaction between alimta and gemcitabine in patients with advanced cancer.
  Adjei A, Erlichman C, Johnson R, Alberts S, Sloan J, Goldberg R, Pitot H, Reid J, Burch P, Rubin J, Eur J Cancer, 10/1/2001
• Join now to see all

Lectures

• "Carcinoid tumors and carcinoid syndrome" 
  Santiago, Chile - 8/1/2004
• "Multiple Modality Approach" 
  New Orleans, LA - 6/1/2004
• "Meet the Professor" 
  5/1/2001
• "How Do We Treat Cancer?" 
  Dubai, United Arab Emirates - 3/1/2001
• "What's New in the Treatment of Gastrointestinal Cancer" 
  Dubai, United Arab Emirates - 3/1/2001
• "New Drugs in GI Malignancies" 
  Paris, France - 1/1/2000
• "Carcinoid Tumors of the GI Tract" 
  Dana Point, CA - 1/1/1999
• Lecture and Round table discussion: "Neuroendocrine Tumors of the Gastrointestinal Tract" 
  Buenos Aires, Argentina - 11/1/1998
• Lecture and Round table discussion: "Adjuvant Treatment of Colon Cancer" 
  Buenos Aires, Argentina - 11/1/1998
• Lecture and Round table discussion: "Toxicities of Cancer Treatment" 
  Buenos Aires, Argentina - 11/1/1998
• "Immunotherapy of Metastatic Disease by Direct Gene Transfer of the HLA-B7B7/Beta2 Microglobulin Genes" 
  Crete, Greece - 8/1/1998
• "Colon and Lung Cancer in U.S." 
  Kuching Sarawak, Malaysia - 7/1/1998
• "Treatment of Colorectal Metastases; Intratumoral Injection of the HLA-B7 Beta microglobulin" 
  Memorial Sloan Kettering, New York City, NY - 2/1/1998
• "Neuroendocrine Tumors of the GI Tract" 
  New York City, NY - 11/1/1997
• "Concepts of Chemotherapy" 
  Kuching Sarawak, Malaysia - 10/1/1997
• "Neuroendocrine Tumors of the Gastrointestinal Tract" 
  5/1/1997
• "Results of a Randomized Study of the Safety, Tolerability, and Efficacy of Multiple Double Blind Dose Levels of Otreotide Acetate LAR Given at Four Week Intervals vs.... 
  5/1/1997
• "Sandostatin LAR, A Randomized Trial" 
  Innsbruck, Austria - 3/1/1997
• "Carcinoid and Islet Cell Tumors; Application and Benefits of Chemotherapy in Colorectal Cancer (Two talks, chairing one symposium) 
  Singapore - 10/1/1995
• "Phase I Study of Immunotherapy of Hepatic Metastasis of Colorectal Carcinoma by Direct Gene Transfer" 
  5/1/1995
• Visiting Professor, Rounds, Conferences: "Neuroendocrine Carcinomas" 
  Singapore - 1/1/1994
• Visiting Professor, Rounds, Conferences: "CEA in Screening for Colon Cancer" 
  Singapore - 1/1/1994
• Visiting Professor, Rounds, Conferences: "Role of Chemotherapy in Metastatic Disease" 
  Singapore - 1/1/1994
• Visiting Professor, Rounds, Conferences: "Chemotherapy for Colon Cancer" 
  Singapore - 1/1/1994
• Visiting Professor, Rounds, Conferences: "Rectal Cancer as an Example of Multidisciplinary approach to Cancer Care" 
  Singapore - 1/1/1994
• Join now to see all